SG Urges Justices To Reject Hatch-Waxman Safe Harbor Case

Law360, New York (December 17, 2012, 9:39 PM EST) -- The federal government told the U.S. Supreme Court on Thursday that safe-harbor provision of the Hatch-Waxman Act can cover allegedly infringing activities that occur after government approval of a drug, and urged the court not to weigh in on the issue.

U.S. Solicitor General Donald Verrilli told the justices to reject an appeal by GlaxoSmithKline PLC in a patent dispute with Classen Immunotherapies Inc., even though he said the Federal Circuit had reached the wrong decision in the case.

The dispute centers on the act's safe...
To view the full article, register now.